Depo-Provera Brain Tumor (Meningioma)
Depo-Provera brain tumor (meningioma) - MDL 3140 consolidated in N.D. Florida, litigation ramping
Connected settlement administrations (1)
- Depo-Provera Brain Tumor Lawsuits
Recent signals
- Depo-Provera Lawsuit Settlement - Consumer Notice
- New Study Adds to Evidence Depo-Provera Injections Cause Meningioma Brain Tumor Risks - AboutLawsuits.com
- Pfizer's Depo-Provera Settlement: What Women With Meningioma Need to Know About the June 2026 Agreement - JD Supra
- Depo-Provera Lawsuit (July 2026) Who Qualifies & How to File - Drugwatch.com
- Statute of Limitations on Depo-Provera Claims Nationwide (2026) - Sokolove Law
- Her Case Matters Explains the Upcoming June 24 Depo-Provera(R) Hearing for Women Who Trusted the Birth Control - reflector.com
- Her Case Matters Explains the Upcoming June 24 Depo-Provera(R) Hearing for Women Who Trusted the Birth Control - reflector.com
- Pfizer Reaches Tentative Settlement in Depo-Provera Cases, Bellwether Trial Vacated - Law.com
- Depo-Provera: Risks, FDA Warnings and Legal Concerns - Drugwatch.com
- Depo-Provera Brain Tumor MDL Adds 1,700 Cases in One Month - The Legal Examiner
Products: depo-proveradepo proveramedroxyprogesteronemedroxyprogesterone acetatebirth control shotcontraceptive injection
Frequently asked questions
Who qualifies for the Depo-Provera Brain Tumor (Meningioma) case?
You may qualify if the following applies to you: Received two or more Depo-Provera birth-control injections and were later diagnosed with a meningioma or other brain tumor. Eligibility criteria can change as the case develops.
How much could a Depo-Provera Brain Tumor (Meningioma) claim be worth?
Estimated payouts range from $50,000 to $1,500,000 depending on individual circumstances. These are estimates based on comparable outcomes, not guarantees.
What is the current status of the Depo-Provera Brain Tumor (Meningioma) case?
In litigation. Pfizer faces a fast-growing wave of lawsuits alleging its injectable contraceptive Depo-Provera (medroxyprogesterone acetate) causes intracranial meningioma, a brain tumor. A 2024 BMJ study found prolonged use was associated with a materially elevated meningioma risk, and plaintiffs allege Pfizer failed to warn US users despite carrying such warnings abroad. The federal cases were consolidated in February 2025 as MDL No. 3140 in the Northern District of Florida before Judge M. Casey Rodgers; bellwether selection and discovery are underway and no settlement exists yet. Eligibility centers on repeated Depo-Provera use and a meningioma diagnosis.
How do I check whether I'm included?
Take the free 30-second audit at https://www.getclaimscout.com/audit and claimscout matches the brands and products you've used against every active class action settlements and mass torts it tracks, or review the eligibility details at https://www.getclaimscout.com/matters/depo-provera.
Think this might apply to you?
Take a 30-second audit and we'll match every brand you've used against active settlements.